Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07615738 · ClinicalTrials.gov registry record · NA
SpO2 Infant and Pediatric Study
A NA study, sponsored by GE Healthcare.
- Not yet
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT07615738 is a NA study that has not yet begun recruiting, run by GE Healthcare. The registered enrollment target is 180 participants.
The verdict
NCT07615738, a NA study, has not yet begun recruiting, sponsored by GE Healthcare.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability of usable data, performance across skin tones, and user feedback.
Interventions
- DEVICE SpO2 Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07615738
The ClinicalTrials.gov registry entry for NCT07615738 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpO2 Sensor is the first listed.
NCT07615738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07615738 about?
NCT07615738 is a clinical study titled "SpO2 Infant and Pediatric Study". This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability ...
What is the current status of trial NCT07615738?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-06-15. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07615738?
The interventions under investigation include: SpO2 Sensor (DEVICE).
Who is sponsoring clinical trial NCT07615738?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.